2026 Zizhang Sheng: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	48	4375	4043	1984	1818	105	18422

Overview

Zizhang Sheng is affiliated with Columbia University in the United States. Their research primarily spans the field of Medicine, with a focus on Infectious Diseases, Epidemiology, Molecular Biology, Immunology, and Radiology, Nuclear Medicine and Imaging. Their work involves extensive investigation into viral infections and immune response mechanisms.

Sheng has contributed significantly to topics including:

SARS-CoV-2 and COVID-19 Research
Monoclonal and Polyclonal Antibodies Research
COVID-19 Clinical Research Studies
Influenza Virus Research Studies
HIV Research and Treatment
SARS-CoV-2 detection and testing
Viral gastroenteritis research and epidemiology

The scientist has collaborated frequently with several researchers, notably:

Yicheng Guo (61 coauthored publications)
Lawrence Shapiro (47 coauthored publications)
David D. Ho (41 coauthored publications)
Lihong Liu (35 coauthored publications)
Yaoxing Huang (35 coauthored publications)

Sheng's work has been published most often in the following venues:

bioRxiv (Cold Spring Harbor Laboratory), 24 publications
Nature, 8 publications
EMPIAR dataset, 8 publications
Cell Reports, 5 publications
Cell Host & Microbe, 4 publications

Among their recent papers are:

"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike," 2020, Nature
"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2," 2021, Nature
"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants," 2022, Cell
"Antibody evasion properties of SARS-CoV-2 Omicron sublineages," 2022, Nature
"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5," 2022, Nature

Best Publications

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Unknown

2383
Citations
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.

Pengfei Wang;Manoj S. Nair;Lihong Liu;Sho Iketani;Sho Iketani

2148
Citations
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.

Lihong Liu;Pengfei Wang;Manoj S. Nair;Jian Yu

1478
Citations
Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Unknown

1473
Citations
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

Unknown

1325
Citations
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

Unknown

980
Citations
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

Unknown

533
Citations
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.

Gabriele Cerutti;Yicheng Guo;Tongqing Zhou;Jason Gorman

523
Citations
SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasion

Unknown

416
Citations
Isolation of a novel swine influenza virus from Oklahoma in 2011 which is distantly related to human influenza C viruses.

Ben M. Hause;Mariette F Ducatez;Emily A. Collin;Zhiguang Ran

414
Citations
Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family

Ben M. Hause;Emily A. Collin;Runxia Liu;Bing Huang

408
Citations
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou

406
Citations
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization

Pengfei Wang;Manoj S Nair;Lihong Liu;Sho Iketani;Sho Iketani

385
Citations
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

Mattia Bonsignori;Tongqing Zhou;Zizhang Sheng;Lei Chen

332
Citations
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

K. Xu;P. Acharya;R. Kong;C. Cheng

298
Citations
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.

Xueling Wu;Xueling Wu;Zhenhai Zhang;Chaim A. Schramm;M. Gordon Joyce

278
Citations
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.

Ming Tian;Ming Tian;Cheng Cheng;Xuejun Chen;Hongying Duan

252
Citations
Cocirculation of Two Distinct Genetic and Antigenic Lineages of Proposed Influenza D Virus in Cattle

Emily A. Collin;Emily A. Collin;Zizhang Sheng;Yuekun Lang;Wenjun Ma

192
Citations
Cryo-EM structure of the SARS-CoV-2 Omicron spike

Unknown

189
Citations
A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York

Medini K Annavajhala;Hiroshi Mohri;Pengfei Wang;Manoj S Nair

185
Citations
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection.

Takuya Yamamoto;Rebecca M. Lynch;Rajeev Gautam;Rodrigo Matus-Nicodemos

124
Citations
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization

David Ho;Pengfei Wang;Lihong Liu;Sho Iketani

110
Citations
Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.

Medini K. Annavajhala;Hiroshi Mohri;Pengfei Wang;Manoj Nair

100
Citations
Analysis of immunoglobulin transcripts and hypermutation following SHIV AD8 infection and protein-plus-adjuvant immunization

Joseph R. Francica;Zizhang Sheng;Zhenhai Zhang;Yoshiaki Nishimura

97
Citations
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

R. Kong;H. Duan;Z. Sheng;K. Xu

94
Citations
Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike.

Lihong Liu;Pengfei Wang;Manoj S Nair;Jian Yu

59
Citations
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

Kai Xu;Priyamvada Acharya;Rui Kong;Cheng Cheng

4
Citations